PUBLIC CONTRACT · 2019
Adalimumab biossimilar 40 mg (doentes em tratamento
- Contract value
- €7,200.00
- Signed on
- 11 October 2019
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 6057181PUBLISHED DESCRIPTION
AQUISIÇÃO IMEDIATA DE ADALIMUMAB BIOSSIMILAR 40 MG (DOENTES EM TRATAMENTO), AO ABRIGO DO ACORDO QUADRO 2018/064 DOS SPMS, EPE
Parties involved
- Place of performance
- Portugal, Coimbra, Figueira da Foz
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL · Tax ID 506415740
Values and timeline
- Contract price
- €7,200.00
- Procedure base price
- €7,200.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 26 November 2019
- Award date
- 11 October 2019
- Signing date
- 11 October 2019
- Performance period
- 98 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Preço ou custo
- CPV code
- 33652000-5 - Antineoplásicos e imunomoduladores
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2018/64 - Medicamentos Diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4276835
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.